4D Molecular Therapeutics, Inc. (FDMT) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 405.36M | 413.13M | 312.38M | 303.29M | 332.57M | 434.93M | 510.76M | 552.63M | 535.59M | 296.59M | 328.24M | 317.78M |
| Cash & Short-Term Investments | 390.89M | 402.65M | 305.06M | 293.23M | 321.44M | 424.88M | 501.89M | 541.95M | 525.91M | 288.23M | 319.66M | 310.34M |
| Cash Only | 72.49M | 60.24M | 48.55M | 77.16M | 133.53M | 149.34M | 187.54M | 189.06M | 275.59M | 249.11M | 275.68M | 236.31M |
| Short-Term Investments | 318.4M | 342.41M | 256.51M | 216.07M | 187.91M | 275.54M | 314.35M | 352.88M | 250.32M | 39.12M | 43.99M | 74.03M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 14.47M | 10.48M | 7.31M | 10.06M | 11.13M | 10.05M | 8.87M | 10.69M | 9.68M | 8.36M | 8.58M | 7.43M |
| Total Non-Current Assets | 107.54M | 153.58M | 111.61M | 170.35M | 183.16M | 125.45M | 93.27M | 67.48M | 94.3M | 43.3M | 33.37M | 34.73M |
| Property, Plant & Equipment | 30.94M | 33.01M | 35.06M | 37.15M | 39.12M | 40.61M | 41.63M | 29.45M | 30.58M | 31.66M | 32.69M | 33.65M |
| Fixed Asset Turnover | 0.10x | 2.50x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | -0.00x | 0.61x | 0.01x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 111.38M | 67.17M | 123.81M | 137M | 80.58M | 48.78M | 35.72M | 62.94M | 10.95M | 0 | 0 |
| Other Non-Current Assets | 76.6M | 9.19M | 9.38M | 9.39M | 7.04M | 4.26M | 2.86M | 2.32M | 771K | 684K | 682K | 1.08M |
| Total Assets | 512.9M | 566.71M | 423.98M | 473.64M | 515.73M | 560.38M | 604.03M | 620.12M | 629.88M | 339.89M | 361.61M | 352.5M |
| Asset Turnover | 0.01x | 0.17x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | -0.00x | 0.06x | 0.00x |
| Asset Growth % | -0.55% | 1.13% | -29.81% | -23.62% | -18.12% | 64.87% | 67.04% | 75.92% | 158.13% | 29.81% | 29.07% | 16.36% |
| Total Current Liabilities | 43.4M | 43.98M | 37.11M | 34.68M | 26.9M | 29.15M | 29.46M | 19.4M | 16.4M | 18.95M | 18.16M | 13.75M |
| Accounts Payable | 14.69M | 11.16M | 6.86M | 8.7M | 4.15M | 4.39M | 2.92M | 3.43M | 4.22M | 3.52M | 4.71M | 3.49M |
| Days Payables Outstanding | 566.08 | 418.69 | 15.16 | 12.19 | - | 188.49 | - | 10.92 | 12.62 | 14.54 | 15.06 | 11.38 |
| Short-Term Debt | 5.49M | 5.59M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 360K | 360K | 360K | 1.07M | 866K | 257K | 35K | 0 | 0 | 273K | 130K | 576K |
| Other Current Liabilities | 22.87M | 26.87M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.87M | 0 | 0 |
| Current Ratio | 9.34x | 9.39x | 8.42x | 8.75x | 12.36x | 14.92x | 17.33x | 28.48x | 32.65x | 15.65x | 18.07x | 23.11x |
| Quick Ratio | 9.34x | 9.39x | 8.42x | 8.75x | 12.36x | 14.92x | 17.33x | 28.48x | 32.65x | 15.65x | 18.07x | 23.11x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 17.66M | 17.06M | 17.89M | 18.07M | 19.11M | 20.63M | 21.61M | 12.37M | 12.92M | 13.11M | 13.52M | 13.61M |
| Long-Term Debt | 15.05M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 15.82M | 16.57M | 17.36M | 18.17M | 18.97M | 19.74M | 10.46M | 11M | 11.52M | 12.03M | 12.53M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 2.62M | 496K | 489K | 495K | 499K | 603K | 592K | 596K | 600K | 617K | 389K | 236K |
| Total Liabilities | 61.07M | 61.05M | 55M | 52.75M | 46.01M | 49.78M | 51.08M | 31.78M | 29.32M | 32.06M | 31.68M | 27.36M |
| Total Debt | 20.54M | 21.41M | 22.26M | 23.08M | 23.85M | 24.61M | 24.83M | 13.66M | 14.17M | 14.67M | 15.16M | 15.63M |
| Net Debt | -51.95M | -38.83M | -26.29M | -54.08M | -109.67M | -124.73M | -162.71M | -175.41M | -261.42M | -234.44M | -260.52M | -220.68M |
| Debt / Equity | 0.05x | 0.04x | 0.06x | 0.05x | 0.05x | 0.05x | 0.04x | 0.02x | 0.02x | 0.05x | 0.05x | 0.05x |
| Debt / EBITDA | - | 2.03x | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | -3.69x | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 451.84M | 505.66M | 368.98M | 420.89M | 469.72M | 510.61M | 552.95M | 588.34M | 600.56M | 307.83M | 329.93M | 325.14M |
| Equity Growth % | -3.81% | -0.97% | -33.27% | -28.46% | -21.79% | 65.87% | 67.59% | 80.95% | 174.72% | 33.07% | 31.22% | 19.31% |
| Book Value per Share | 6.64 | 8.73 | 6.57 | 7.53 | 8.43 | 9.47 | 9.95 | 10.64 | 12.19 | 7.87 | 7.81 | 8.48 |
| Total Shareholders' Equity | 451.84M | 505.66M | 368.98M | 420.89M | 469.72M | 510.61M | 552.95M | 588.34M | 600.56M | 307.83M | 329.93M | 325.14M |
| Common Stock | 5K | 6K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 4K | 4K | 4K |
| Retained Earnings | -785.06M | -716.3M | -735.7M | -678.83M | -624.17M | -576.2M | -526.52M | -482.68M | -447.73M | -415.33M | -383.04M | -372.79M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -180K | 727K | 671K | 337K | 332K | 229K | 1.08M | -293K | -109K | 16K | 534K | 345K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |